HEALTHCARE SERVICES GROUP INC quarterly report, Q2 FY2023

Business context and reporting period

Healthcare Services Group, Inc. filed this unaudited Form 10-Q for the quarter ended June 30, 2023. It manages housekeeping, laundry, linen, facility maintenance and dietary services, primarily for U.S. healthcare facilities. Results are reported for Housekeeping and Dietary.

Financial performance and liquidity

Operating cash flow was negative $8.9 million in the first half, compared with negative $21.2 million a year earlier; management attributed the 2023 outflow primarily to higher receivables from the timing of customer payments. Investing cash flow was negative $0.6 million and financing cash flow was positive $11.9 million. Cash and equivalents were $28.7 million at June 30.

Cash, cash equivalents and marketable securities totaled $121.8 million, and working capital was $359.4 million; the current ratio was 2.9. The company had $40.0 million drawn on its $300 million revolving credit facility, plus $85.7 million in standby letters of credit that reduced available facility capacity to $174.3 million. It reported compliance with its financial covenants. Six-month interest expense was $3.7 million, up from $1.0 million.

Material changes versus the prior comparable period

• Q2 revenue declined 1.4%; first-half revenue declined 1.8%. Housekeeping revenue fell 4.1% in both periods, mainly because fewer facilities were serviced. Dietary revenue rose 1.0% in Q2 and 0.2% in the first half, supported by contractual pass-throughs of labor and food costs despite fewer facilities.
• Profit improved despite lower revenue. First-half income before tax rose 20.5% and net income rose 17.3%. Lower service costs as a share of revenue contributed, while results also benefited from deferred-compensation investment movements and improved investment and other income versus 2022 losses.
• First-half SG&A rose 25.3% to $81.5 million, partly reflecting a $14.0 million year-over-year swing in deferred-compensation-plan effects. Excluding those effects, SG&A increased 3.2%, primarily due to travel expenses and inflation.
• The allowance for doubtful accounts increased to $79.7 million from $73.5 million at year-end 2022. Bad-debt provision was $18.2 million in the first half; management cited receivable aging.
• The board suspended the quarterly dividend in February 2023 and authorized repurchases of up to 7.5 million shares. The company repurchased 0.2 million shares for $2.2 million in the first half; none were repurchased in Q2.

Outlook, risks and unusual items

• Management estimated 2023 capital expenditures of $4.0 million to $6.0 million; $2.1 million had been spent through June 30. It said available cash, operating cash flows and credit capacity should be adequate for the foreseeable future, while noting there is no assurance.
• Management described persistent inflation, labor shortages and wage growth, below-target nursing-home occupancy and workforce participation, and continued pandemic-related effects. Cost increases may pressure results if they cannot be passed through to customers.
• Customer concentration and collection risk are important: a significant portion of revenue came from one customer during the six months, but the filing text does not provide a clear value for that share. Many customers depend on Medicare, Medicaid and other reimbursement funding. Delayed payments, customer financial distress or bankruptcy could increase bad debts.
• The company filed a claim for Employee Retention Credits related to 2020 and 2021 wages. It had received no refund or IRS correspondence through July 28, 2023, and recognized no benefit because it did not consider receipt reasonably assured.
• Pending legal claims include labor and employee-related matters; possible losses could not be reasonably estimated for certain claims. Management said it could not assess whether their outcome may materially affect the company. Tax matters also remain with various jurisdictions, though management did not expect them to have a material adverse effect.
• Deferred-compensation investment values create period-to-period volatility in SG&A and investment and other income. The company also cited interest-rate risk on fixed- and floating-rate investments.

Important facts for investors to verify

• Whether receivables convert to cash and whether the elevated allowance and bad-debt provision adequately reflect customer credit risk.
• Revenue trends by segment, facility counts, and the extent to which contractual cost pass-throughs offset customer attrition and inflation.
• Future operating cash flow, revolver borrowings, interest costs, covenant headroom and availability after letters of credit.
• The impact of the dividend suspension and share-repurchase authorization on capital allocation and per-share results.
• Any IRS action or refund related to the ERC claim, and developments in pending legal and tax matters.